C H Unnikrishnan in Mumbai

US investment firm eyes pharma buyouts

Rediff.com 19 Aug 2006

Mid-cap drug firms beat big peers in 1st quarter

Rediff.com 14 Aug 2006

ResMed makes India foray

Rediff.com 10 Aug 2006

Kolkata group against GSK's AIDS patent

Rediff.com 8 Aug 2006

TCS develops gene-based malaria cure

Rediff.com 8 Aug 2006

Diageo set to re-enter IMFL mart

Rediff.com 7 Aug 2006

Strides may go for buyouts in Europe

Rediff.com 4 Aug 2006

TCS seeks to deprive cyber pirates of loot

Rediff.com 2 Aug 2006

Mumbai police probe Novartis cheating case

Rediff.com 28 Jul 2006

Security scanner on research FDI

Rediff.com 22 Jul 2006

Mallya raises a toast, wine segment on a high

Rediff.com 14 Jul 2006

GSK to use gel to enter OTC erectile market

Rediff.com 12 Jul 2006

Wockhardt bets big on Farex turnaround

Rediff.com 4 Jul 2006

Claris Life inks pact with German major

Rediff.com 19 Jun 2006

Paul Cap to set up drug development venture

Rediff.com 15 Jun 2006

BPCL sales via Petrocard cross Rs 7,000 cr

Rediff.com 14 Jun 2006

TCG to buy clinical trials firm

Rediff.com 1 Jun 2006

Pharma intermediates mart to touch $590 m

Rediff.com 31 May 2006

Pharma intermediates mart to touch $590 m

Rediff.com 31 May 2006

Wockhardt eyes US, China buys

Rediff.com 29 May 2006

C H Unnikrishnan In Mumbai

Stories by C H Unnikrishnan In Mumbai

US investment firm eyes pharma buyouts

Mid-cap drug firms beat big peers in 1st quarter

ResMed makes India foray

Kolkata group against GSK's AIDS patent

TCS develops gene-based malaria cure

Diageo set to re-enter IMFL mart

Strides may go for buyouts in Europe

TCS seeks to deprive cyber pirates of loot

Mumbai police probe Novartis cheating case

Security scanner on research FDI

Mallya raises a toast, wine segment on a high

GSK to use gel to enter OTC erectile market

Wockhardt bets big on Farex turnaround

Claris Life inks pact with German major

Paul Cap to set up drug development venture

BPCL sales via Petrocard cross Rs 7,000 cr

TCG to buy clinical trials firm

Pharma intermediates mart to touch $590 m

Pharma intermediates mart to touch $590 m

Wockhardt eyes US, China buys